Roy Ervin Twyman
Direktor/Vorstandsmitglied bei AC IMMUNE SA
Vermögen: 78 204 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Roy Ervin Twyman
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
27
| Public Company | Pharmaceuticals: Major | 27 |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ.
8
| Subsidiary | Miscellaneous Commercial Services | 8 |
Syndesi Therapeutics SA
 Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
NeuroVision Imaging LLC
 NeuroVision Imaging LLC Packaged SoftwareTechnology Services NeuroVision Imaging LLC develops digital imaging and diagnostic solutions for Alzheimer's disease and eye care markets. The firm offers CHARIOT:PRO, NVI0007, and A4. The company was founded by Keith L. Black, Maya Koronyo-Hamaoui, Yosef Koronyo, and Steven R. Verdooner in 2010 and is headquartered in Sacramento, CA.
4
| Holding Company | Packaged Software | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Roy Ervin Twyman
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Lausanne | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member Treasurer | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
Inventages II
 Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Investment Managers | Founder Founder | |
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| École Polytechnique Fédérale de Lausanne | College/University | Graduate Degree Doctorate Degree | |
| Janssen Biotherapeutics | Corporate Officer/Principal Corporate Officer/Principal | ||
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | Private Equity Investor Private Equity Investor | |
| GERON CORPORATION | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Graduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
HUBER+SUHNER (UK) Ltd.
 HUBER+SUHNER (UK) Ltd. Electronic Production EquipmentElectronic Technology HUBER+SUHNER (UK) Ltd. manufactures, imports, and sells electrical and optical connectivity components and accessories. It offers radio frequency and fiber optic products including antennas, assemblies, cables, connectors and adapters, lightning and EMP protectors, and resistive components. The company was founded on March 30, 1967 and is headquartered in Bicester, the United Kingdom. | Electronic Production Equipment | Director/Board Member | |
| Gebert Rüf Stiftung | Corporate Officer/Principal | ||
| University of Tilburg | College/University | Corporate Officer/Principal | |
| Max Schmidheiny-Stiftung | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| Richard Büchner Foundation | Director/Board Member | ||
| Swiss Society of Economics & Statistics | President | ||
| Swiss Institute For Intl Economics & Applied Economic Research | Chairman | ||
| SCHWEIZERISCHE NATIONALBANK | Major Banks | Director/Board Member | |
| SCHINDLER HOLDING AG | Industrial Machinery | Director/Board Member | |
| Swiss Federal Commission for Economic Issues | Corporate Officer/Principal | ||
| Network for Studies on Pensions Aging Retirement | Corporate Officer/Principal | ||
| CESifo Research Network | Corporate Officer/Principal | ||
| Center for Disability & Integration | Corporate Officer/Principal | ||
| HUBER+SUHNER AG | Telecommunications Equipment | Director/Board Member | |
Glenmark Pharmaceuticals Inc., USA
 Glenmark Pharmaceuticals Inc., USA Pharmaceuticals: MajorHealth Technology Glenmark Pharmaceuticals USA, Inc. manufactures, markets, and distributes generic pharmaceutical products. It offers campral delayed-release tablets, differin gel, aclovate cream, aclovate topical ointment, ortho novum, and other related products. The company was founded in 2003 and is headquartered in Mahwah, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Suva City Council | Corporate Officer/Principal | ||
Walden Biosciences, Inc.
 Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | Medical/Nursing Services | Director/Board Member | |
| University of Medicine & Dentistry of New Jersey | College/University | Corporate Officer/Principal | |
Rutgers Cancer Institute of New Jersey
 Rutgers Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Rutgers Cancer Institute of New Jersey, in partnership with RWJBarnabas Health, is the only National Cancer Institute-designated comprehensive cancer center in New Jersey. Rutgers Cancer Institute has locations in New Brunswick and at University Hospital in Newark, as well as through RWJBarnabas Health facilities. The institute offers advanced cancer treatment options, including bone marrow transplantation, proton therapy, CAR T-cell therapy, and complex surgical procedures. Patients have access to cutting-edge therapies such as precision medicine and immunotherapy, many of which are not widely available. The top cancer researchers and clinicians throughout the state collaborate to apply the latest technologies, therapies, and approaches to improve cancer diagnosis and treatment. | Hospital/Nursing Management | Director/Board Member | |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Investment Managers | Private Equity Investor | |
| IMD College | College/University | Masters Business Admin | |
| Université Libre de Bruxelles | College/University | Graduate Degree | |
| University of Liege | College/University | Undergraduate Degree | |
EsoBiotec SA
 EsoBiotec SA Miscellaneous Commercial ServicesCommercial Services EsoBiotec SA is a Belgian company that provides research and development on natural sciences and engineering. The company is based in Charleroi, Belgium. The company was founded in 2020 by Jean-Pierre Latere. Jean-Pierre Latere has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
UCB Ventures (Private Equity)
 UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures is the venture capital arm of UCB SA and was founded in 2016. UCB Ventures is headquartered in Brussels, Belgium with additional offices in Boston, Massachusetts and London, United Kingdom. | Investment Managers | Private Equity Investor | |
| SWISS LIFE HOLDING AG | Life/Health Insurance | Director/Board Member | |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Technical Institute of Jiangsu | College/University | Undergraduate Degree | |
| World Demographic & Ageing Forum | Corporate Officer/Principal | ||
Abiogen Pharma SpA
 Abiogen Pharma SpA Miscellaneous Commercial ServicesCommercial Services Abiogen Pharma SpA manufactures and develops pharmaceutical products. The firm offers therapeutic drugs in the anti-inflammatory and painkiller, respiratory, bone metabolism, and dermatology areas. The company was founded by Massimo di Martino in 1997 and is headquartered in Pisa, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Schweizerische Management Gesellschaft | Director/Board Member |
Statistik
International
| Schweiz | 18 |
| Vereinigte Staaten | 15 |
| Belgien | 7 |
| Deutschland | 4 |
| Niederlande | 4 |
Sektoral
| Health Technology | 12 |
| Consumer Services | 11 |
| Finance | 8 |
| Commercial Services | 4 |
| Health Services | 4 |
Operativ
| Director/Board Member | 148 |
| Corporate Officer/Principal | 90 |
| Chief Tech/Sci/R&D Officer | 37 |
| Doctorate Degree | 32 |
| Chairman | 32 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Friedrich von Bohlen und Halbach | 36 |
| Alan Colowick | 30 |
| Douglas Williams | 25 |
| Monika Bütler | 25 |
| Fiona MacLaughlin | 22 |
| Mathai Mammen | 16 |
| Martin Velasco | 15 |
| Christina Takke | 14 |
| William Hait | 13 |
| Werner Lanthaler | 12 |
| Andrea Pfeifer | 11 |
| Thomas Graney | 11 |
| Emmanuel Lacroix | 10 |
| Robert Friesen | 9 |
| Carl June | 9 |
- Börse
- Insiders
- Roy Ervin Twyman
- Unternehmensverbindungen
